<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20220608055103N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-10-04</date_registration>
      <primary_sponsor>Rasht University of Medical Sciences</primary_sponsor>
      <public_title>tympanoplasty results using gelfoam block , autologus fat and mix of fat and gelfoam in Chronic Otitis Media</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of tympanoplasty results using gelfoam block support, autologus fat blocks and mix of fat and gelfoam blocks in Chronic Otitis Media: A Clinical Trial studyl</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-07-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>96</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/65181</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: The method of random allocation in 3 groups is based on random blocks, the sequence of which will be determined based on Table of random numbers. The list of this sequence of samples in 3 groups will be kept in the ENT research center in a sealed envelope and will be read gradually after the start of the study based on the inclusion criteria of the patients. Then, according to the patient group based on randomization, on the graft and in the area of the perforation connection with the graft, gelfoam is used in group A, and fat block in group B, and the combination of gelfoam and fat block pressed together is used in group C. The external ear canal is packed by Gelfoam in all 3 groups, Blinding description: The method of random allocation in 3 groups is based on random blocks, the sequence of which will be determined based on Table of random numbers. The list of this sequence of samples in 3 groups will be kept in the ENT research center in a sealed envelope and will be read gradually after the start of the study based on the inclusion criteria of the patients. After collecting the patients according to the random block, the participants are assigned to one of the groups A to c. Patients are not aware of their allocation to treatment groups. Based on the group mentioned in the received envelope, the treating doctor performs one of the treatment measures for the patient. The evaluation of the eardrum transplant result is done one month later by a specialist assistant who The patients are unaware of the therapeutic action taken. The follow-up of the patients is carried out for up to one month by the attending physician who is not aware of the therapeutic action taken.</study_design>
      <phase>3</phase>
      <hc_freetext>Chronic Otitis Media.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: , gelfoam  is used in group A. Intervention 2: Intervention group: Fat block is used in group B.In order to prepare fat blocks, about 0.5 to 1 cubic centimeter is removed from the same place of skin incision and from the fat under the skin, and it is pressed and dried by Fat Presser. Intervention 3: Intervention group: In group C, a combination of gelfoam and fat block pressed together is used. In this group, along with the piece of fat, the same amount of Gelfoam is placed in the Fat Presser and they are pressed and dried together.Then they are cut into blocks and small pieces of 2 x 3 mm by a surgical knife.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
In the case of individual patients data, all potential data will be shared after de-identifying individuals. The result of the clinical study will be published in the form of an article

When:
The access period starts 6 months after  publication of  the results.

To whom:
All researchers

Conditions:
for secondary data analysis and  meta-analysis

Where to obtain:
Dr. shadman nemati, Otorhinolaryngology Research Center. Amiralmomenin Hospital , 17 Shahrivar Street. Bank Melli Square. Rasht.Postal code: 4139638459 -Tell: 01333225242- Mobile: 09111370488- Email: drshadmannemati_ent@yahoo.com

How to obtain:
After receiving the applicant's request and a brief statement of the protocol in which the mentioned information is used, a Preliminary  review will be  done and the information will be  sent to the researcher within 2 weeks

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Shadman Nemati</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>17 shahrivar street, bank melli square, Amiralmomenin Hospital</address>
        <city>Rasht</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4139638459</zip>
        <telephone>+98 13 3322 5242</telephone>
        <email>drshadmannemati_ent@yahoo.com</email>
        <affiliation>Rasht University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Shadman Nemati</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>17 shahrivar street, bank melli square, Amiralmomenin Hospital</address>
        <city>Rasht</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4139638459</zip>
        <telephone>+98 13 3322 5242</telephone>
        <email>drshadmannemati_ent@yahoo.com</email>
        <affiliation>Rasht University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>All patients with chronic otitis media with simple TM perforation and the age range of 18 to 65 years</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>ABG &gt; 40 db
ossicular disorders
Evidence  of cholesteatoma
Complete perforation without edge (at least 2 mm) TM
Active otorrhea during recent a month
Presence of large and thick plaques of tympanosclerosis in the edges of perforation
underlying diseases such as diabetes, hypothyroidy, severe uremia, bleeding diseases, immunodeficiency diseases
smoking
Evidence in favor of Eustachian tube disorder, such as bilateral perforation, bilateral otorrhea, atelectatic ears, etc</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>H72.0</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Central perforation of tympanic membrane</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Surgery</i_code>
      <i_code>Treatment - Surgery</i_code>
      <i_code>Treatment - Surgery</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: , gelfoam  is used in group A.</i_keyword>
      <i_keyword>Intervention group: Fat block is used in group B.In order to prepare fat blocks, about 0.5 to 1 cubic centimeter is removed from the same place of skin incision and from the fat under the skin, and it is pressed and dried by Fat Presser</i_keyword>
      <i_keyword>Intervention group: In group C, a combination of gelfoam and fat block pressed together is used. In this group, along with the piece of fat, the same amount of Gelfoam is placed in the Fat Presser and they are pressed and dried together.Then they are cut into blocks and small pieces of 2 x 3 mm by a surgical knife.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Link success rate. Timepoint: before surgery and 3 months after surgery. Method of measurement: Pure tone audiometry at frequencies of 512, 1024, 2048 Hz is used to measure ABG, and tympanogram and the amount and location of its peak (types A, B, C) are used to check the health of the new tympanic membrane.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>(ABG rate ) air bone gap. Timepoint: before surgery and 3 months after surgery. Method of measurement: Pure tone audiometry at frequencies of 512, 1024, 2048 Hz is used to measure chatter, and tympanogram and the amount and location of its peak (types A, B, C) are used to check the health of the new tympanic membrane.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Rasht university of medical science</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-06-01</approval_date>
        <contact_name>کمیته اخلاق دانشگاه علوم پزشکی گیلان</contact_name>
        <contact_address>Amiralmomenin Hospital, 17 shahrivar street, bank melli square rasht Guilan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
